Literature DB >> 34748097

First-principles studies on two-dimensional B3O3 adsorbent as a potential drug delivery platform for TEPA anticancer drug.

Rezvan Rahimi1,2, Mohammad Solimannejad3,4, Zeynab Ehsanfar5.   

Abstract

The remarkable properties of pristine B3O3 nanosheet as a nanocarrier for adsorption and desorption of TEPA anticancer drug for designing potential drug delivery platform were investigated using periodic DFT calculations. We studied the adsorption energy of all stable complexes formed between the drug molecule and B3O3 in gas and aqueous phases along with electronic structure analysis of complexes. Different adsorption configurations were studied for drug/B3O3 complexes, including the interaction of the C atom of the triangular ring, O atom in the TEPA drug with the B atom in B3O3, and indirect drug interaction the middle of the R1 ring cavity of the B3O3 nanosheet. The take-up of TEPA prompts a substantial change of 68.13% in the band gap (Eg) of the B3O3 nanosheet in the most stable complex. The present study results affirmed the application of B3O3 nanosheet as a potential vehicle for TEPA drugs in the treatment of cancerous tissues.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Anticancer drug; B3O3; Drug delivery; Drug release; TEPA

Mesh:

Substances:

Year:  2021        PMID: 34748097     DOI: 10.1007/s00894-021-04930-x

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  26 in total

1.  Development of a peptide-drug conjugate for prostate cancer therapy.

Authors:  Wanyi Tai; Ravi S Shukla; Bin Qin; Benyi Li; Kun Cheng
Journal:  Mol Pharm       Date:  2011-05-03       Impact factor: 4.939

2.  Immunosuppressive agent leflunomide: a SWNTs-immobilized dihydroortate dehydrogenase inhibitory effect and computational study of its adsorption properties on zigzag single walled (6,0) carbon and boron nitride nanotubes as controlled drug delivery devices.

Authors:  Heidar Raissi; Fariba Mollania
Journal:  Eur J Pharm Sci       Date:  2014-02-22       Impact factor: 4.384

Review 3.  Graphene and graphene oxide as new nanocarriers for drug delivery applications.

Authors:  Jingquan Liu; Liang Cui; Dusan Losic
Journal:  Acta Biomater       Date:  2013-08-16       Impact factor: 8.947

4.  Biological evaluation of a novel doxorubicin-peptide conjugate for targeted delivery to EGF receptor-overexpressing tumor cells.

Authors:  Shibin Ai; Jianli Duan; Xin Liu; Stephanie Bock; Yuan Tian; Zebo Huang
Journal:  Mol Pharm       Date:  2011-02-02       Impact factor: 4.939

5.  Targeted intracellular delivery of antituberculosis drugs to Mycobacterium tuberculosis-infected macrophages via functionalized mesoporous silica nanoparticles.

Authors:  Daniel L Clemens; Bai-Yu Lee; Min Xue; Courtney R Thomas; Huan Meng; Daniel Ferris; Andre E Nel; Jeffrey I Zink; Marcus A Horwitz
Journal:  Antimicrob Agents Chemother       Date:  2012-02-21       Impact factor: 5.191

Review 6.  From combinatorial chemistry to cancer-targeting peptides.

Authors:  Olulanu H Aina; Ruiwu Liu; Julie L Sutcliffe; Jan Marik; Chong-Xian Pan; Kit S Lam
Journal:  Mol Pharm       Date:  2007-09-20       Impact factor: 4.939

Review 7.  Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor.

Authors:  Virginia M Platt; Francis C Szoka
Journal:  Mol Pharm       Date:  2008-06-03       Impact factor: 4.939

8.  Restoring basal planes of graphene oxides for highly efficient loading and delivery of β-lapachone.

Authors:  Xin Ting Zheng; Chang Ming Li
Journal:  Mol Pharm       Date:  2012-02-02       Impact factor: 5.364

9.  Beta-lapachone-containing PEG-PLA polymer micelles as novel nanotherapeutics against NQO1-overexpressing tumor cells.

Authors:  Elvin Blanco; Erik A Bey; Ying Dong; Brent D Weinberg; Damon M Sutton; David A Boothman; Jinming Gao
Journal:  J Control Release       Date:  2007-04-29       Impact factor: 11.467

10.  Enhancement of solubility and bioavailability of beta-lapachone using cyclodextrin inclusion complexes.

Authors:  Norased Nasongkla; Andy F Wiedmann; Andrew Bruening; Meghan Beman; Dale Ray; William G Bornmann; David A Boothman; Jinming Gao
Journal:  Pharm Res       Date:  2003-10       Impact factor: 4.580

View more
  1 in total

1.  Computational NEXAFS Characterization of Molecular Model Systems for 2D Boroxine Frameworks.

Authors:  Daniele Toffoli; Elisa Bernes; Albano Cossaro; Gabriele Balducci; Mauro Stener; Silvia Mauri; Giovanna Fronzoni
Journal:  Nanomaterials (Basel)       Date:  2022-05-09       Impact factor: 5.719

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.